Package 51662-1439-1

Brand: physostigmine salicylate

Generic: physostigmine salicylate
NDC Package

Package Facts

Identity

Package NDC 51662-1439-1
Digits Only 5166214391
Product NDC 51662-1439
Description

2 mL in 1 AMPULE (51662-1439-1)

Marketing

Marketing Status
Marketed Since 2019-12-22
Brand physostigmine salicylate
Generic physostigmine salicylate
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS"], "spl_id": "f1deeef3-92c7-a88e-e053-2a95a90a74a3", "openfda": {"unii": ["2046ZRO9VU"], "rxcui": ["990982"], "spl_set_id": ["9a448a78-356c-50f7-e053-2995a90adefa"], "manufacturer_name": ["HF Acquisition Co LLC, DBA HealthFirst"]}, "finished": true, "packaging": [{"sample": false, "description": "2 mL in 1 AMPULE (51662-1439-1)", "package_ndc": "51662-1439-1", "marketing_start_date": "20191222"}, {"sample": false, "description": "10 POUCH in 1 CASE (51662-1439-3)  / 1 AMPULE in 1 POUCH (51662-1439-2)  / 2 mL in 1 AMPULE", "package_ndc": "51662-1439-3", "marketing_start_date": "20230109"}], "brand_name": "PHYSOSTIGMINE SALICYLATE", "product_id": "51662-1439_f1deeef3-92c7-a88e-e053-2a95a90a74a3", "dosage_form": "INJECTION", "product_ndc": "51662-1439", "generic_name": "PHYSOSTIGMINE SALICYLATE", "labeler_name": "HF Acquisition Co LLC, DBA HealthFirst", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "PHYSOSTIGMINE SALICYLATE", "active_ingredients": [{"name": "PHYSOSTIGMINE SALICYLATE", "strength": "1 mg/mL"}], "marketing_category": "UNAPPROVED DRUG OTHER", "marketing_start_date": "20191222", "listing_expiration_date": "20261231"}